TrialClinical and translational science2025

Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo-Controlled, Parallel Group, First-In-Human Study in Healthy Male Participants.

Marella C E van Ruissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.